Kcr expression was also downregulated in HCC, correlating with the TNM stage, while HDAC1 and HDAC3 simultaneous knockdown or HDACi trichostatin A (TSA) treatment improved the Kcr level, coincidently limiting hepatoma cell motility and proliferation [141]. Here, CLEC4F is linked to hepatocellular carcinoma.